5240752026-05-132026-05-135240752026-05-135240752026-05-13

ChangeInManagementDomain1

5240752026-05-132026-05-13

ChangeInManagementDomain1

xbrli:pure

ALBERTDAVD

ALBERT DAVID LIMITED

524075

NOTLISTED

INE155C01010

true

Listed Entity (self)

true

2026-05-12

11:30:00

17:45:00

2026-05-13

Appointment

Key Managerial Personnel

Chief Executive Officer

Mr.

Amit Mahla

2026-05-12

Amit Mahla, aged 52 years is a seasoned leader with over 28 years of experience, recognized for transforming underperforming businesses into high growth engines. He holds a degree in Science, a postgraduate degree in English Literature, and an Executive MBA (Rank Holder) from SIES, Mumbai. He has led large, P&L-driven portfolios across leading organizations, including Cipla, Emcure, Glenmark, Alembic, Sun Pharma, and JB Pharma. He also brings entrepreneurial leadership experience, having worked with a start-up in Innovcare life sciences. Prior to joining Albert David, he was associated with JB Pharma. He possesses extensive expertise across both acute and chronic segments of the Indian Pharmaceutical Market (IPM), with a strong focus on business transformation and strategic leadership. He has contributed to building over 20 big brands across key therapy areas. He successfully led the integration of Sanzyme into JB Pharma—one of the most significant acquisitions in the IPM in recent times —ensuring seamless portfolio alignment, effective field-force integration, and sustained post-acquisition growth while unlocking strategic synergies. He has consistently demonstrated his ability to turn around challenging businesses, drive new business launches, introduce successful new products, create new categories, and provide thought leadership.